Nerispirdine

DB12714InvestigationalSmall molecule

Nerispirdine has been used in trials studying the treatment of Neuritis, Optic Nerve, and Multiple Sclerosis.

Mechanism: Pharmacologically active on Voltage-gated sodium channel alpha subunit and Voltage-gated Potassium Channels
Curator reviewed
Formula / weight: C₁₇H₁₈FN₃ · 283.35 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyBTDHTARYCBHHPJ-UHFFFAOYSA-NSMILESCCCN(N1C=C(C)C2=CC=CC=C12)C1=CC=NC=C1F

Targets

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nerispirdine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.